Antimalarials in the management of discoid and systemic lupus erythematosus.
D000818:Animals; D000962:Antimalarials / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D002738:Chloroquine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008179:Lupus Erythematosus, Discoid / Q000188:drug therapy*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D010859:Pigmentation Disorders / Q000139:chemically induced; D011796:Quinacrine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D012164:Retinal Diseases / Q000139:chemically induced; D014786:Vision Disorders / Q000139:chemically induced
D000962:Antimalarials; D002738:Chloroquine; D011796:Quinacrine